Skip Navigation

VAERS Bibliography - May 2005

  1. Summaries for Patients. What Is the Most Cost-Effective Way to Protect People in the Event of an Anthrax Terror Attack?   Ann Intern Med; 142 (8): I40; April, 2005.

  2. Resources. "Allergic Asthma for Dummies"...and a Web-Based Tool to Improve Immunizations and Health Screenings.    Child Health Alert; 23:2; April, 2005.

  3. Estimated Influenza Vaccination Coverage Among Adults and Children--United States, September 1, 2004-January 31, 2005.   MMWR Morb Mortal Wkly Rep; 54 (12): 304-307; April 1, 2005.

  4. Aaby, P.; Jensen, H.; Benn, C. S.; Lisse, I. M.  Non-Specific Effects of Vaccination: Survival Bias May Explain Findings.   BMJ; 330 (7495): 844-845; April 9, 2005.

  5. Ajani, U. A.; Ford, E. S.; Mokdad, A. H.  Examining the Coverage of Influenza Vaccination Among People With Cardiovascular Disease in the United States.   Am Heart J; 149 (2): 254-259; February, 2005.

  6. Andrews N.; Miller E.; Grant A.; Stowe J; Osborne V.; Taylor B  Thimerosal Exposure in Infants and Developmental Disorders: A Retrospective Cohort Study in the United Kingdom Does Not Support a Causal Association.   Pediatrics; 114 (3): 584-591; October, 2004.

  7. Broutin, H.; Mantilla-Beniers, N. B.; Simondon, F.; Aaby, P.; Grenfell, B. T.; Guegan, J. F.; Rohani, P.  Epidemiological Impact of Vaccination on the Dynamics of Two Childhood Diseases in Rural Senegal.   Microbes Infect; April 4, 2005. [Epub ahead of print]

  8. Bueving, H. J.; Thomas, S.; van der Wouden, J. C.  Influenza Vaccination in Children With Asthma: No Reason to Change Current Recommendations.   Am J Respir Crit Care Med; 171 (8): 931-932; April 15, 2005.

  9. Burns, V. E.; Ring, C.; Carroll, D.  Factors Influencing Influenza Vaccination Uptake in an Elderly, Community-Based Sample.   Vaccine; 23 (27): 3604-3608; May, 2005.

  10. Czajka, H.  [Alternative Immunization Schedule and Combined Vaccines in Paediatric Practice].   Przegl Epidemiol; 58 Suppl 1:112-6; 2004.

  11. Danek, J.; Czajka, H.; Jawor-Bugajska, M.; Kruk, W.  [Vaccinations As a Cause of Children Hospitalisation in Neuroinfection Department of the John Paul 2nd Hospital in Cracow Between 2002--2004].   Przegl Epidemiol; 58 Suppl 1:117-22; 2004.

  12. Davis, M. M.; Gaglia, M. A.  Associations of Daycare and School Entry Vaccination Requirements With Varicella Immunization Rates.   Vaccine; 23 (23): 3053-3060; April 27, 2005.

  13. Dominguez, A.; Salleras, L.; Fedson, D. S.; Izquierdo, C.; Ruiz, L.; Ciruela, P.; Fenoll, A.; Casal, J.  Effectiveness of Pneumococcal Vaccination for Elderly People in Catalonia, Spain: a Case-Control Study.   Clin Infect Dis; 40 (9): 1250-1257; May 1, 2005.

  14. Fairweather, P.; O'rourke, T.; Strutton, G.  Rare Complication of Q Fever Vaccination.   Australas J Dermatol; 46 (2): 124-125; May, 2005.

  15. Ferrer, A.; Formiga, F.; Lombarte, I.; Marques, M.  [High Percentage of Influenza Vaccination in Nonagenarian Patients After an Educational Programme.].   Med Clin (Barc ); 124 (14): 557-558; April 16, 2005.

  16. Fleming, D. M.; Monto, A. S.  Influenza Vaccination in Children With Asthma: No Reason to Change Current Recommendations.   Am J Respir Crit Care Med; 171 (8): 931; April 15, 2005.

  17. Fowler, R. A.; Sanders, G. D.; Bravata, D. M.; Nouri, B.; Gastwirth, J. M.; Peterson, D.; Broker, A. G.; Garber, A. M.; Owens, D. K.  Cost-Effectiveness of Defending Against Bioterrorism: a Comparison of Vaccination and Antibiotic Prophylaxis Against Anthrax.   Ann Intern Med; 142 (8): 601-610; April, 2005.

  18. Fox, N. C.; Black, R. S.; Gilman, S.; Rossor, M. N.; Griffith, S. G.; Jenkins, L.; Koller, M.  Effects of A{Beta} Immunization (AN1792) on MRI Measures of Cerebral Volume in Alzheimer Disease.   Neurology; April 7, 2005. [Epub ahead of print]

  19. Garcia, D. P.  Living Without Immunizations--a New Growing Trend.   J Ky Med Assoc; 103 (3): 109-111; March, 2005.

  20. Geel, A.; Zuidema, W.; van, Gelder T.; van, Doornum G.; Weimar, W.  Successful Vaccination Against Varicella Zoster Virus Prior to Kidney Transplantation.   Transplant Proc; 37 (2): 952-953; March, 2005.

  21. Gerace, T. M.  Review: Vaccination Reduces the Incidence of Serologically Confirmed Influenza in Healthy Adults.    Evid Based Nurs; 8 (2): 47; April, 2005.

  22. Giacchino, R.; Losurdo, G.; Castagnola, E.   Decline in Mortality With Varicella Vaccination.   N Engl J Med; 352 (17): 1819; April 28, 2005.

  23. Goldman, G. S.  Cost-Benefit Analysis of Universal Varicella Vaccination in the U.S. Taking into Account the Closely Related Herpes-Zoster Epidemiology.   Vaccine; 23 (25): 3349-3355; May 9, 2005.

  24. Hansen, O.  [Acute Brachial Neuropathy Following Influenza Vaccination].   Ugeskr Laeger; 167 (11): 1297-1298; March 14, 2005.

  25. Hatakeyama, S.; Moriya, K.; Saijo, M.; Morisawa, Y.; Kurane, I.; Koike, K.; Kimura, S.; Morikawa, S.  Persisting Humoral Antiviral Immunity Within the Japanese Population After the Discontinuation in 1976 of Routine Smallpox Vaccinations.   Clin Diagn Lab Immunol; 12 (4): 520-524; April, 2005.

  26. Heymann, D. L.; Sutter, R. W.; Aylward, R. B.  A Global Call for New Polio Vaccines.   Nature; 434 (7034): 699-700; April 7, 2005.

  27. Holzman, G. S.; Harwell, T. S.; Johnson, E. A.; Goldbaum, G.; Helgerson, S. D.  A Media Campaign to Promote Pneumococcal Vaccinations: Is a Telephone Survey an Effective Evaluation Strategy?   J Public Health Manag Pract; 11 (3): 228-234; May, 2005.

  28. Hubicki, L.; Czech, E.; Kowalska, M.; Zejda, J. E.  [Childhood Immunization Rate in Families of Various Social-Economical Status in Town of Bytom].   Przegl Epidemiol; 58 (4): 713-723; 2004.

  29. Hussein, A. A.; Musa, A. O.  Experiencing Service Learning: Students of a New Medical School As Vaccinators and Independent Monitors.   Educ Health (Abingdon ); 17 (3): 385-387; November, 2004.

  30. Ikonen, N.; Pyhala, R.; Axelin, T.; Kleemola, M.; Korpela, H.  Reappearance of Influenza B/Victoria/2/87-Lineage Viruses: Epidemic Activity, Genetic Diversity and Vaccination Efficacy in the Finnish Defence Forces.   Epidemiol Infect; 133 (2): 263-271; April, 2005.

  31. Isaacs, D.; Lawrence, G.; Boyd, I.; Ronaldson, K.; McEwen, J.  Reporting of Adverse Events Following Immunization in Australia.   J Paediatr Child Health; 41 (4): 163-166; April, 2005.

  32. Jensen, H.; Benn, C. S.; Aaby, P.  DTP in Low Income Countries: Improved Child Survival or Survival Bias?   BMJ; 330 (7495): 845-846; April 9, 2005.

  33. Jimenez-Garcia, R.; Mayo-Montero, E.; Hernandez-Barrera, V.; Sierra-Moros, M. J.; Pachon, del Amo, I; Carrasco-Garrido, P.; Martinez-Hernandez, D.; de Miguel, A. G.  Evolution of Anti-Influenza Vaccination Coverage in Spain From 1993 to 2001.   Vaccine; 23 (22): 2844-2850; April 22, 2005.

  34. Kemper, A. R.; Cowan, A. E.; Ching, P. L.; Davis, M. M.; Kennedy, E. J.; Clark, S. J.; Freed, G. L.  Hospital Decision-Making Regarding the Smallpox Pre-Event Vaccination Program.   Biosecur Bioterror; 3 (1): 23-30; 2005.

  35. Krizova, P.  [Present Possibilities of Anti-Meningococcal Vaccination].   Klin Mikrobiol Infekc Lek; 11 (1): 25-29; February, 2005.

  36. MacDonald, M.  Parents' Decisions on MMR Vaccination for Their Children Were Based on Personal Experience Rather Than Scientific Evidence.   Evid Based Nurs; 8 (2): 60; April, 2005.

  37. Marco, Hernandez M.  [Reasons for the 2003-2004 Meningitis C Vaccination Campaign in Castilla-La Mancha.].   An Pediatr (Barc ); 62 (4): 381-382; April, 2005.

  38. Marin, M.; Nguyen, H. Q.; Keen, J.; Jumaan, A. O.; Mellen, P. M.; Hayes, E. B.; Gensheimer, K. F.; Gunderman-King, J.; Seward, J. F.  Importance of Catch-Up Vaccination: Experience From a Varicella Outbreak, Maine, 2002-2003.   Pediatrics; 115 (4): 900-905; April, 2005.

  39. Martignon, G.; Oryszczyn, M. P.; nnesi-Maesano, I.  Does Childhood Immunization Against Infectious Diseases Protect From the Development of Atopic Disease?   Pediatr Allergy Immunol; 16 (3): 193-200; May, 2005.

  40. Mascarenas, A.; Salinas, J.; Tasset-Tisseau, A.; Mascarenas, C.; Khan, M. M.  Polio Immunization Policy in Mexico: Economic Assessment of Current Practice and Future Alternatives.   Public Health; 119 (6): 542-549; June, 2005.

  41. Matyasova, I.  [Poliomyelitis Surveillance in the Czech Republic From the Start of Vaccination to the Certification of Eradication in the European Region].   Epidemiol Mikrobiol Imunol; 54 (1): 16-20; February, 2005.

  42. McInerny, T. K.; Cull, W. L.; Yudkowsky, B. K.  Physician Reimbursement Levels and Adherence to American Academy of Pediatrics Well-Visit and Immunization Recommendations.   Pediatrics; 115 (4): 833-838; April, 2005.

  43. Moss, A. L.  Lessons in Giving Vaccines: Soft Tissue Complications of Vaccinations.   J Public Health (Oxf); 27 (2): 236-237; April 8, 2005.

  44. Motlova, J.  [Disribution of Streptococcus Pneumoniae Serotypes and Serogroups Among Patients With Invasive Pneumococcal Diseases in the Czech Republic in 1996-2003: Background Data for Vaccination Strategy].   Epidemiol Mikrobiol Imunol; 54 (1): 3-10; February, 2005.

  45. Munoz, F. M.; Greisinger, A. J.; Wehmanen, O. A.; Mouzoon, M. E.; Hoyle, J. C.; Smith, F. A.; Glezen, W. P.  Safety of Influenza Vaccination During Pregnancy.   Am J Obstet Gynecol; 192 (4): 1098-1106; April, 2005.

  46. Nakhla, I.; Frenck, R. W., Jr.; Teleb, N. A.; Oun, S. E.; Sultan, Y.; Mansour, H.; Mahoney, F.  The Changing Epidemiology of Meningococcal Meningitis After Introduction of Bivalent A/C Polysaccharide Vaccine into School-Based Vaccination Programs in Egypt.   Vaccine; 23 (25): 3288-3293; May 9, 2005.

  47. Nilsson, L.; Faldella, G.; Jacquet, J. M.; Storsaeter, J.; Silfverdal, S. A.; Ekholm, L.  A Fourth Dose of DTPa-IPV Vaccine Given to 4-6 Year Old Children in Italy and Sweden Following Primary Vaccination at 3, 5 and 11-12 Months of Age.   Scand J Infect Dis; 37 (3): 221-229; 2005.

  48. Offit, P. A.  The Cutter Incident, 50 Years Later.   N Engl J Med; 352 (14): 1411-1412; April 7, 2005.

  49. Pachon, del Amo, I  [Impact of Vaccination Programmes in Spain.].   Aten Primaria; 35 (6): 314-317; April 15, 2005.

  50. Partidos, C. D.; Muller, S.  Decision-Making at the Surface of the Intact or Barrier Disrupted Skin: Potential Applications for Vaccination or Therapy.   Cell Mol Life Sci; April 7, 2005. [Epub ahead of print]

  51. Richards, S.  One Jab Benefits All. Assessing the Impact of Extending the Vaccination Programme.   Nurs Stand; 19 (29): 19; March 30, 2005.

  52. Rinaldo, C. R., Jr.  Passive Immunization Against Poliomyelitis: the Hammon Gamma Globulin Field Trials, 1951-1953.   Am J Public Health; 95 (5): 790-799; May, 2005.

  53. Russell, M. L.; Yau, A.; Baptiste, B.; Rowntree, C.; Robb, J.; Hill, S.  Improving the Public Health/Physician Partnership for Influenza Vaccination.   Can J Public Health; 96 (2): 155-158; March, 2005.

  54. Salmon, D. A.; Sapsin, J. W.; Teret, S.; Jacobs, R. F.; Thompson, J. W.; Ryan, K.; Halsey, N. A.  Public Health and the Politics of School Immunization Requirements.   Am J Public Health; 95 (5): 778-783; May, 2005.

  55. Shann, F.  Non-Specific Effects of Vaccination: Vaccines Have Non-Specific (Heterologous) Effects.   BMJ; 330 (7495): 844; April 9, 2005.

  56. Sherpa, T. Y.; Leaf, H. L.  Pneumococcal Vaccination in Adults.   Curr Infect Dis Rep; 7 (3): 211-217; May, 2005.

  57. Siddiqui, A.; Usmani, R. I.; Anwer, S.; Afsar, S.  Guillain-Barre Syndrome Occurring After Rabies Vaccination.   J Pak Med Assoc; 55 (2): 87-88; February, 2005.

  58. Sinha, A.; Lieu, T. A.; Paoletti, L. C.; Weinstein, M. C.; Platt, R.  The Projected Health Benefits of Maternal Group B Streptococcal Vaccination in the Era of Chemoprophylaxis.   Vaccine; 23 (24): 3187-3195; May 2, 2005.

  59. Szucs, T. D.  Meningococcal Vaccination: Cui Bono?   Pharmacoeconomics; 23 (4): 315-316; 2005.

  60. Tavares, E. C.; Ribeiro, J. G.; Oliveira, L. A.  [Active and Passive Immunization in the Extremely Preterm Infant].   J Pediatr (Rio J ); 81 (1 Suppl): S89-S94; March, 2005.

  61. Taylor, L.; Tan, C. G.; Liu, S.; Miro, S.; Genese, C. A.; Bresnitz, E. A.  New Jersey's Smallpox Vaccination Clinic Experiences, 2003.   J Public Health Manag Pract; 11 (3): 216-221; May, 2005.

  62. Timmermans, D. R.; Henneman, L.; Hirasing, R. A.; van der, Wal G.  Attitudes and Risk Perception of Parents of Different Ethnic Backgrounds Regarding Meningococcal C Vaccination.   Vaccine; 23 (25): 3329-3335; May 9, 2005.

  63. Tjalma, W. A.; Damme, P. V.  Is the Public Enough Aware to Accept a Vaccination Program Against Human Papillomavirus?   Vaccine; 23 (25): 3231; May 9, 2005.

  64. Valli, L.  Logical to Vaccinate Rather Than Risk Infection.   Can Vet J; 46 (2): 108; February, 2005.

  65. Wahid, R.; Cannon, M. J.; Chow, M.  Virus-Specific CD4+ and CD8+ Cytotoxic T-Cell Responses and Long-Term T-Cell Memory in Individuals Vaccinated Against Polio.   J Virol; 79 (10): 5988-5995; May, 2005.

  66. Webb, G. F.  Being Prepared: Modeling the Response to an Anthrax Attack.   Ann Intern Med; 142 (8): 667-668; April, 2005.

  67. Wilson, K.; Mills, E. J.; Norman, G.; Tomlinson, G.  Changing Attitudes Towards Polio Vaccination: a Randomized Trial of an Evidence-Based Presentation Versus a Presentation From a Polio Survivor.   Vaccine; 23 (23): 3010-3015; April 27, 2005.

  68. Wu, T. H.; Hutt, J. A.; Garrison, K. A.; Berliba, L. S.; Zhou, Y.; Lyons, C. R.  Intranasal Vaccination Induces Protective Immunity Against Intranasal Infection With Virulent Francisella Tularensis Biovar A.   Infect Immun; 73 (5): 2644-2654; May, 2005.